News

news

Dr. Reid Robison Interviewed by Daily Hive
news

What Are the Benefits of Microdosing? | Goop
news

Meet Payton Nyquvest | Psychedelia Magazine
news

Numinus Completes Acquisition of Neurology Centre of Toronto
news

Numinus to Participate in Upcoming Investor Conferences in September 2021
news

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology
news

MDMA-Assisted Therapy for PTSD: In conversation with Rick Doblin & Payton Nyquvest
news

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
news

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology
news

Numinus Announces Update to Escrow Release Schedule
news

Numinus Announces Grant of Stock Options
news

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species
news

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange
news

‘People are desperate to heal’: The push for psychedelic-assisted therapy in Canada
news

FR: Numinus Wellness annonce le recrutement de dirigeants clés pour soutenir sa croissance rapide et l’innovation
news

Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation
news

FR: Numinus Wellness et Optimi Health soumettent un extrait de psilocybine entièrement naturelle à Santé Canada en vue d’une demande d’essai pré-clinique
news

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
news

Numinus celebrates Mental Health Week 2021
news

Numinus builds on strong MAPS Phase 3 trial results through Compassionate Access Trial of MDMA for PTSD
news

Numinus Congratulates MAPS on Phase 3 Clinical Trial of MDMA for severe PTSD
news

FR: Numinus félicite MAPS pour son essai clinique de phase 3 révélant des bienfaits significatifs de la thérapie assistée par MDMA dans le traitement du SSPT grave
news

Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD
news

Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC
news

FR: Numinus annonce un essai clinique de phase 1 sur l’extraction naturelle de champignons psilocybe préparée au laboratoire de la société
news

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab
news

Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants
news

There Is a Lot of Fungus Among Us
news

FR: Numinus annonce la clôture d’un financement par voie de prise ferme de 40 M$
news

Numinus Announces Closing of $40-Million Bought Deal Financing
news

FR: Numinus Wellness Inc. annonce un placement public de 30 M$ par voie de prise ferme
news

Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 Million
news

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering
news

FR: Numinus agrandira son laboratoire de recherche ultramoderne sur les psychédéliques
news

Numinus to expand state-of-the-art psychedelics research laboratory
news

FR: Les laboratoires Numinus au premier plan de la recherche mondiale sur les psychédéliques suite aux autorisations réglementaires
news

Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research
news

FR: Numinus et Syreon fournissent une mise à jour concernant les essais cliniques à accès compassionnel sur la psilocybine
news

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update
news

Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness
news

Numinus Wellness’s trial for MDMA-assisted therapy is in pre-implementation stage
news

FR: Numinus annonce des avancées dans les essais cliniques à accès compassionnel pour la thérapie assistée par MDMA en collaboration avec MAPS Public Benefit Corporation
news

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation
news

FR: Numinus Wellness finalise l’acquisition de Mindspace Wellbeing, basée à Montréal
news

Numinus Wellness Completes Acquisition of Montreal-based Mindspace Wellbeing
news

Numinus Engages Native Ads Inc. for Digital Media Services
news

Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts
news

FR: Numinus Wellness fait avancer la recherche axée sur la découverte en matière de psychédéliques grâce au spectromètre de masse Orbitrap Exploris 120
news

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer
news

FR: Numinus et Optimi Health signent une entente de services de laboratoire pour faire progresser la recherche et le développement de produits psychédéliques
news

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products
news

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option
news

FR: Une clinique montréalaise offre des thérapies assistées à la kétamine
news

Numinus Completes First Extraction of its Psilocybe Mushrooms
news

Numinus Wellness Acquires Mindspace Wellbeing to Expand into Montreal
news

FR: Numinus Wellness annonce son expansion nationale avec l’acquisition de Mindspace Wellbeing, un organisme de bien-être à services complets basé à Montréal et pionnier en matière de thérapies psychédéliques
news

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming
news

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme
news

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering
news

Numinus Wellness Inc. Announces $10 Million Bought Deal Public Offering
news

Numinus and MAPS to Collaborate on MDMA Trial for PTSD
news

Experts favour use of magic mushroom derivatives for research into mental health treatment
news

“Buried by Puppies Licking Your Face” (Canadian Firms Champion MDMA for PTSD)
news

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
news

New Magic Mushroom Clinical Trial to Treat Addiction
news

Vancouver company announces clinical trial of psilocybin-assisted psychotherapy for substance use disorders
news

As medicine rediscovers magic mushrooms, a Montreal clinic says there’s no time to waste
news

Down (the Rabbit Hole) and Out (of Addiction)
news

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
news

Veterans Suffering from PTSD Find Relief Through Psilocybin
news

Numinus Becomes The First Canadian Psychedelics Company To Legally Harvest Magic Mushrooms
news

Vancouver company completes first legal harvest of psilocybe mushrooms
news

Numinus Announces First Legal Harvest of Psilocybe Mushrooms
news

Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms
news

Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
news

How Numinus plans to support psychedelic assisted psychotherapy access to Canadians and beyond
news

Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
news

Numinus Announces Listing of Warrants
news

Numinus Announces Closing of Oversubscribed $4.6 Million Offering
news

Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000
news

Numinus and Together We Can Partner to Support Addiction Recovery and Mental Wellness
news

Numinus Announces Short Form Prospectus Offering of Units for Gross Proceeds of up to $4,050,000
news

Numinus Announces Short Form Prospectus Offering of Units for Gross Proceeds of up to $4.05 Million
news

Company with Nanaimo lab gets federal approval for psychedelic drug research
news

Conversations That Matter: Payton Nyquvest and Dr. Evan Wood
news

Healthcare company Numinus believes psychedelic assisted therapy can improve mental health outcomes
news

Numinus announces Clinical Advisory Council to advance integrated wellness model
news

The business of producing psychedelics for science
news

Numinus licensed by Health Canada to extract and research psilocybin
news

Numinus Licencing Amendment: We Speak to the Team
news

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms
news

Dr. Devon Christie, MD CCFP RTC IFMCP, joins Numinus as Medical Director
news

Numinus Announces 2020 Operational Plans to Scale
news

Growing body of research shows patients with addiction, PTSD, and depression can benefit from psychedelic substances
news

Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council
news

B.C. MP calls for legalization of some psychedelic drugs
news

Canada could regulate psychedelic therapy within few years, bets company
news

Psilocybin Alpha speaks with Dr. Evan Wood, CMO at Numinus
news

Vancouver-based Numinus Wellness hires addiction expert Dr. Evan Wood as chief medical officer
news

Dr. Evan Wood, recognized leader in the field of substance use research and treatment, joins Numinus as Chief Medical Officer
news

Numinus Wellness Inc. commences trading on TSX Venture Exchange as NUMI
news

Numinus Wellness Inc. (formerly Rojo Resources Ltd.) closes RTO with Salvation Botanicals LTD; to commence trading under “NUMI”
news

Rojo Resources Ltd. announces the conditional approval of reverse take-over transaction with Salvation Botanicals Ltd.
news

Rojo Resources Ltd. announces closing of subscription receipt offering, Salvation Botanicals closes sidecar private placement – aggregate gross proceeds of $6,000,000 raised
news

End-to-end solution in psychedelic therapies establishes Numinus as leader in emerging space
news

Stacey Wallin & Payton Nyquvest – Waking up to a new consciousness

We want to connect with you!

Sign up here so we can keep in touch.